Report is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Albany, NY -- (SBWire) -- 04/05/2017 --A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).

Request Free Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1048255

Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

According to Market research Hub, "Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years

The report titled, "Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)

Antibody Drug Conjugates Market (ADC) Market
Adcetris Market
Kadcyla Market
ADC Pipeline - By Developer, Phase, Indication and Status
ADC Pipeline - By Cytotoxic Payload, Linker and Target

Regional Markets – N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)

Antibody Drug Conjugates Market (ADC) Market
Adcetris Market
Kadcyla Market
ADC Pipeline - By Developer, Phase, Indication and Status
ADC Pipeline - By Cytotoxic Payload, Linker and Target

Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)

Antibody Drug Conjugates Market (ADC) Market

Other Report Highlights:

Market Dynamics – Trends, Drivers, Challenges
Porter's Five Forces Analysis
SWOT Analysis
Policy and Regulation
Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals

Read Full Report with TOC@ http://www.marketresearchhub.com/report/global-antibody-drug-conjugates-adc-market-report.html

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

RELATED REPORTS:

1: Global Deep Brain Stimulation (DBS)Market Size, Status and Forecast 2022:- http://www.marketresearchhub.com/report/global-deep-brain-stimulation-dbsmarket-size-status-and-forecast-2022-report.html

2: Global Granulocyte-Macrophage Colony Stimulating Factor Market Research Report 2017:-http://www.marketresearchhub.com/report/global-granulocyte-macrophage-colony-stimulating-factor-market-research-report-2017-report.html

3: Global Nucleic Acid Isolation and Purification Market Size, Status and Forecast 2022:-http://www.marketresearchhub.com/report/global-nucleic-acid-isolation-and-purification-market-size-status-and-forecast-2022-report.html

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of Healthcare Market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
LinkedIn: https://www.linkedin.com/company/market-research-hub
Facebook: https://www.facebook.com/MarketResearchHub/
Twitter: https://twitter.com/MktResearchHub